Skip to main navigation Skip to search Skip to main content

A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes

  • E. J. Rhee
  • , W. Y. Lee
  • , K. H. Yoon
  • , S. J. Yoo
  • , I. K. Lee
  • , S. H. Baik
  • , Y. K. Kim
  • , M. K. Lee
  • , K. S. Park
  • , J. Y. Park
  • , B. S. Cha
  • , H. W. Lee
  • , K. W. Min
  • , H. Y. Bae
  • , M. J. Kim
  • , J. A. Kim
  • , D. K. Kim
  • , Sun Woo Kim*
    • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

38   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science